Has Lauren Hardiman received payments from drug or device companies?

Yes. Drug and device makers reported $6,634 in general payments to Lauren Hardiman across 299 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lauren Hardiman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lauren Hardiman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lauren Hardiman

Nurse Practitioner · Brandon, FLNPI 1619381167

Payments from drug & device makers

$6,634in general payments, 2019–2025

Across 299 payments — averaging $22.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$686
E.r. Squibb & Sons, L.L.C.$574
Merck$429
AstraZeneca$417
Pfizer$340
Daiichi Sankyo Inc.$291
plus $4K from 53 others

What the payments were for

Food & beverage$6,634100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	38	$686
E.r. Squibb & Sons, L.L.C.	32	$574
Merck	18	$429
AstraZeneca(2 entities)	20	$417
Pfizer	18	$340
Daiichi Sankyo Inc.	11	$291
AbbVie	11	$276
Bristol Myers Squibb	11	$262
Sanofi	10	$237
Johnson & Johnson(2 entities)	9	$233
Eisai Inc.	9	$214
Genentech USA, Inc.	4	$184
Blueprint Medicines Corporation	3	$173
Lilly USA, LLC	7	$155
Regeneron Healthcare Solutions, Inc.	6	$144
Gilead(2 entities)	5	$119
Seagen Inc.	7	$117
Array Biopharma Inc	4	$91
Takeda Pharmaceuticals U.S.A., Inc.	4	$88
Beigene USA, Inc.	4	$86
Incyte Corporation	4	$84
Stemline Therapeutics Inc.	3	$79
Myriad Genetic Laboratories, Inc.	2	$78
GSK	3	$66
Pharmacosmos Therapeutics Inc.	3	$64
Geron Corporation	3	$63
AVEO Pharmaceuticals, Inc.	3	$62
Sumitomo Pharma America, Inc.	3	$60
Pharmaessentia USA Corporation	2	$58
Boehringer Ingelheim	2	$52
Legend Biotech USA Inc.	2	$52
Amgen	3	$50
Pharmacyclics LLC, An Abbvie Company	2	$48
Sobi, Inc	2	$46
Alnylam Pharmaceuticals Inc.	2	$40
Bayer	2	$39
Rigel Pharmaceuticals, Inc.	1	$34
Beone Medicines USA, Inc.	2	$34
Agios Pharmaceuticals, Inc.	2	$34
CTI Biopharma Corp.	2	$31
Taiho Oncology, Inc.	2	$30
Astellas Pharma US Inc	1	$29
Springworks Therapeutics, Inc.	1	$27
Jazz Pharmaceuticals Inc.	1	$27
Dendreon Pharmaceuticals LLC	1	$27
Kyowa Kirin, Inc.	1	$26
EMD Serono, Inc.	1	$26
Genmab U.S., Inc.	1	$25
ADC Therapeutics America, Inc.	1	$25
Mirati Therapeutics, Inc.	1	$25
Adaptive Biotechnologies Corporation	1	$24
TG Therapeutics, Inc.	1	$23
Recordati_rare_diseases_inc.	1	$22
Syndax Pharmaceuticals, Inc.	1	$21
Servier Pharmaceuticals LLC	1	$21
Karyopharm Therapeutics Inc.	1	$18
Deciphera Pharmaceuticals Inc.	1	$17
GE HealthCare	1	$16
Iovance Biotherapeutics, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TECENTRIQ$125
AYVAKIT$125

How this compares

$6,634 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$24,648
Letrozole	49	$1,377
Tamoxifen Citrate	14	$724
Prochlorperazine Maleate	20	$408
Dexamethasone	13	$236
Pantoprazole Sodium	16	$203
Lidocaine-PrilocaineLidocaine/Prilocaine	14	$146
Warfarin Sodium	13	$135

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$340	$24,64821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Brandon

Jolanta BaginskiClearwater$494K
Adissa PerezWinter Park$370K
April WessonTampa$342K
Margarita FernandezMiami$311K
Stephanie SimmermanNaples$283K
Claudette WalkerPonte Vedra Beach$271K
Lisa NodzonTampa$246K
Ashima BahlTampa$226K
Maya BloombergMiami$202K
Jennifer PuleoTampa$171K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →